Works matching DE "CEFTAZIDIME"
Results: 1608
FDA approves cUTI agent.
- Published in:
- Urology Times, 2015, v. 43, n. 3, p. 8
- Publication type:
- Article
Rectourethral fistula as the presentation of disseminated urogenital meliodosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Characterization and pathogenicity of Aeromonas veronii associated with mortality in cage farmed grass carp, Ctenopharyngodon idella (Valenciennes, 1844) from the Central Himalayan region of India.
- Published in:
- Antonie van Leeuwenhoek, 2020, v. 113, n. 12, p. 2063, doi. 10.1007/s10482-020-01478-3
- By:
- Publication type:
- Article
Necrotizing fasciitis, causative agents and management: a five-year retrospective study in two tertiary care hospitals in Central Malaysia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 10, p. 2813, doi. 10.1007/s00417-023-06112-2
- By:
- Publication type:
- Article
Selecting the dosage of ceftazidime–avibactam in the perfect storm of nosocomial pneumonia.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 3, p. 349, doi. 10.1007/s00228-019-02804-z
- By:
- Publication type:
- Article
Psychrobacter piechaudii shunt infection: first report of human infection.
- Published in:
- Child's Nervous System, 2022, v. 38, n. 7, p. 1385, doi. 10.1007/s00381-021-05401-7
- By:
- Publication type:
- Article
INFECTIONS: New antimicrobial drugs near approval.
- Published in:
- Podiatrist, 2022, v. 25, n. 4, p. 7
- Publication type:
- Article
Investigation of Cephalosporin and Heavy Metal Resistance of Aeromonas hydrophila and Pseudomonas aeruginosa Strains Isolated from Hospital Sewage in Türkiye.
- Published in:
- Acta Aquatica Turcica, 2023, v. 19, n. 4, p. 312, doi. 10.22392/actaquatr.1241122
- By:
- Publication type:
- Article
Evaluation of In Vitro Activity of Ceftolozane-tazobactam and Ceftazidime-avibactam Against Carbapenemase-producing Multi-drug Resistant Klebsiella pneumoniae Isolates.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2020, v. 9, p. 76, doi. 10.4274/mjima.galenos.2020.2020.11
- By:
- Publication type:
- Article
The In Vitro Release Study Of Ceftazidime drug From Synthesized Strontium Flourapatite And Strontium Hydroxyapatite Coated Particles.
- Published in:
- Karbala Journal of Pharmaceutical Sciences, 2017, n. 13, p. 137
- By:
- Publication type:
- Article
犊牛肺炎大肠杆菌的分离鉴定、耐药性及致病力检测.
- Published in:
- Chinese Journal of Preventive Veterinary Medicine / Zhongguo Yufang Shouyi Xuebao, 2023, v. 45, n. 1, p. 100, doi. 10.3969/j.issn.1008-0589.202204042
- By:
- Publication type:
- Article
奶牛场沙门氏菌分离株的流行特征及抗性分析.
- Published in:
- Modern Food Science & Technology, 2022, v. 38, n. 10, p. 261, doi. 10.13982/j.mfst.1673-9078.2022.10.1441
- By:
- Publication type:
- Article
In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
- Published in:
- Turkish Journal of Medical Sciences, 2019, v. 49, n. 2, p. 683, doi. 10.3906/sag-1808-55
- By:
- Publication type:
- Article
Investigation of the effect of β-lactam antibiotics and serum on growth and gene expression in Escherichia coli strain JJ1886.
- Published in:
- Turkish Journal of Medical Sciences, 2018, v. 48, n. 6, p. 1340, doi. 10.3906/sag-1803-121
- By:
- Publication type:
- Article
Pseudomonas species from cattle dung producing extended spectrum and metallo beta-lactamases.
- Published in:
- European Journal of Biological Research, 2020, v. 10, n. 1, p. 1, doi. 10.5281/zenodo.3630802
- By:
- Publication type:
- Article
Efficacy of Cefiderocol Against Endophthalmitis Isolates.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 12, p. 1236, doi. 10.3390/antibiotics13121236
- By:
- Publication type:
- Article
Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 9, p. 862, doi. 10.3390/antibiotics13090862
- By:
- Publication type:
- Article
Loading Dose of Ceftazidime Needs to Be Increased in Critically Ill Patients: A Retrospective Study to Evaluate Recommended Loading Dose with Pharmacokinetic Modelling.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 8, p. 756, doi. 10.3390/antibiotics13080756
- By:
- Publication type:
- Article
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 6, p. 564, doi. 10.3390/antibiotics13060564
- By:
- Publication type:
- Article
Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 5, p. 445, doi. 10.3390/antibiotics13050445
- By:
- Publication type:
- Article
Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Pseudomonas aeruginosa Biofilm.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 4, p. 344, doi. 10.3390/antibiotics13040344
- By:
- Publication type:
- Article
Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 4, p. 337, doi. 10.3390/antibiotics13040337
- By:
- Publication type:
- Article
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 285, doi. 10.3390/antibiotics13030285
- By:
- Publication type:
- Article
The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 3, p. 265, doi. 10.3390/antibiotics13030265
- By:
- Publication type:
- Article
In Vitro Antibacterial Activity of Ceftobiprole and Comparator Compounds against Nation-Wide Bloodstream Isolates and Different Sequence Types of MRSA.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 2, p. 165, doi. 10.3390/antibiotics13020165
- By:
- Publication type:
- Article
Drug Discovery in the Field of β-Lactams: An Academic Perspective.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 1, p. 59, doi. 10.3390/antibiotics13010059
- By:
- Publication type:
- Article
The Klebsiella pneumoniae carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 1, p. 40, doi. 10.3390/antibiotics13010040
- By:
- Publication type:
- Article
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 12, p. 1707, doi. 10.3390/antibiotics12121707
- By:
- Publication type:
- Article
Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 11, p. 1612, doi. 10.3390/antibiotics12111612
- By:
- Publication type:
- Article
Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 10, p. 1521, doi. 10.3390/antibiotics12101521
- By:
- Publication type:
- Article
In Vitro Activity of New β-Lactamase Inhibitor Combinations against bla NDM , bla KPC , and ESBL-Producing Enterobacteriales Uropathogens.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 10, p. 1481, doi. 10.3390/antibiotics12101481
- By:
- Publication type:
- Article
Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 7, p. 1146, doi. 10.3390/antibiotics12071146
- By:
- Publication type:
- Article
Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against Klebsiella pneumoniae by MALDI-TOF MS.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 6, p. 1063, doi. 10.3390/antibiotics12061063
- By:
- Publication type:
- Article
The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 5, p. 892, doi. 10.3390/antibiotics12050892
- By:
- Publication type:
- Article
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 5, p. 820, doi. 10.3390/antibiotics12050820
- By:
- Publication type:
- Article
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography–Tandem Mass Spectrometry for Therapeutic Drug Monitoring.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 719, doi. 10.3390/antibiotics12040719
- By:
- Publication type:
- Article
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 644, doi. 10.3390/antibiotics12040644
- By:
- Publication type:
- Article
Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 4, p. 633, doi. 10.3390/antibiotics12040633
- By:
- Publication type:
- Article
Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 469, doi. 10.3390/antibiotics12030469
- By:
- Publication type:
- Article
Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 1, p. 169, doi. 10.3390/antibiotics12010169
- By:
- Publication type:
- Article
In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 1, p. 102, doi. 10.3390/antibiotics12010102
- By:
- Publication type:
- Article
Genomic Characterization of KPC-31 and OXA-181 Klebsiella pneumoniae Resistant to New Generation of β-Lactam/β-Lactamase Inhibitor Combinations.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 1, p. 10, doi. 10.3390/antibiotics12010010
- By:
- Publication type:
- Article
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 12, p. 1681, doi. 10.3390/antibiotics11121681
- By:
- Publication type:
- Article
Antibiotic Susceptibility and Minimum Inhibitory Concentration for Stenotrophomonas maltophilia Ocular Infections.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 11, p. 1457, doi. 10.3390/antibiotics11111457
- By:
- Publication type:
- Article
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa : In Vivo and In Vitro Evidence.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 11, p. 1456, doi. 10.3390/antibiotics11111456
- By:
- Publication type:
- Article
A Seven-Year Microbiological and Molecular Study of Bacteremias Due to Carbapenemase-Producing Klebsiella Pneumoniae : An Interrupted Time-Series Analysis of Changes in the Carbapenemase Gene's Distribution after Introduction of Ceftazidime/Avibactam.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101414
- By:
- Publication type:
- Article
Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101404
- By:
- Publication type:
- Article
Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101280
- By:
- Publication type:
- Article
Guanidinylated Polymyxins as Outer Membrane Permeabilizers Capable of Potentiating Rifampicin, Erythromycin, Ceftazidime and Aztreonam against Gram-Negative Bacteria.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 10, p. N.PAG, doi. 10.3390/antibiotics11101277
- By:
- Publication type:
- Article